| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 720,284 | 461,075 | 347,372 | 627,324 | | Cost of Revenue | 615,112 | 377,830 | 279,359 | 510,626 | | | Gross Profit | 105,172 | 83,245 | 68,013 | 116,698 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 60,465 | 55,669 | 53,632 | 59,188 | | Non Recurring | (1,549) | (2,808) | (2,521) | (939) | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 46,256 | 30,384 | 16,902 | 58,449 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 3,806 | 2,540 | 5,846 | 9,515 | | Earnings Before Interest And Taxes | 54,083 | 33,707 | 22,304 | 68,342 | | Interest Expense | 4,245 | 2,853 | 3,488 | 3,130 | | Income Before Tax | 49,838 | 30,854 | 18,816 | 65,212 | | Income Tax Expense | 13,300 | 8,187 | 4,829 | 21,011 | | Minority Interest | (15,725) |
-
|
-
| (12,276) | | | | Net Income From Continuing Ops | 20,813 | 22,667 | 13,987 | 31,925 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 20,813 | 22,667 | 13,987 | 31,925 | | Preferred Stock And Other Adjustments | 9,785 | (4,718) | (5,067) |
-
| | | Net Income Applicable To Common Shares | $30,598 | $17,949 | $8,920 | $31,925 |
|
2.03% Nasdaq 
Income Statement
